Background
Malaria is a major public health threat in many parts of the globe and is responsible for half a million deaths annually. According to the World Malaria Report 2019, an estimated 228 million persons suffered from malaria worldwide, with 435,000 malaria deaths in 2018 [
1].
Plasmodium falciparum is the parasite that cause 99.7% malaria cases in African regions [
1].
The sub-Saharan African country, Equatorial Guinea has a total population of 1.31 million (2018). Bioko, an island of Equatorial Guinea off the coast of Cameroon, with historically high malaria transmission. The Bioko Island Malaria Elimination Project (BIMEP) is a fusion of two long-standing anti-malaria programmes (Bioko Island Malaria Control Project, BIMCP and Equatorial Guinea Malaria Vaccine Initiative, EGMVI) in Equatorial Guinea, with Medical Care Development Institution (MCDI) as the lead implementing partner [
2‐
4]. Recently evaluations indicated that malaria prevalence had dropped considerably from 43.3 to 10.5% between 2004 and 2016, resulting in a 13.3% reduction of moderate to severe anaemia in children aged 1–5 years. Despite considerable success in reducing the burden on the island, malaria is still a major public health concern in Bioko Island.
Malaria infection in humans starts when infected female
Anopheles mosquitoes take their blood meal and inject sporozoites into the host (human) skin. Sporozoites quickly pass into the liver, where they infect hepatocytes. Thrombospondin-related adhesive protein (TRAP) is the most extensively studied
Plasmodium transmembrane protein and it would be released on the surface when the sporozoite into contact with the host cell [
5].
Plasmodium TRAP also assists the sporozoite in several pivotal functions, such as sporozoite gliding motility, hepatocyte invasion and establishment of infection in the vertebrate host [
6‐
8]. The
P. falciparum TRAP (
PfTRAP) extracellular domain (ECD) consists of three domains/motifs that include the A-domain (similar to the A-or I-domain which is found in integrins), the TSP (thrombospondin repeat motif, a heparin-binding module, also called the RII region) and a proline-rich segment at the C-terminus [
9]. The previous studies [
10] revealed a higher frequency of nonsynonymous to synonymous single nucleotide polymorphisms (SNPs) of TRAP within the
P. falciparum population of Gambian and Thailand. In their studies, McDonald–Kreitman test showed that the ratio of the number of nonsynonymous to synonymous SNPs within
P. falciparum was significantly higher than that of the number of nonsynonymous to synonymous fixed sites between
P. falciparum and
Plasmodium reichenowi. Furthermore, the value of Tajima’D test and Fu and Li’s test also suggested that the TRAP gene is under diversifying selection in the
P. falciparum population in Gambian and Thailand [
10]. However, no evidence for balancing selection was reported for parasites obtained from sub-Saharan African countries, except The Gambia. Thus, it remains unclear whether positive selection acts on the TRAP gene of
P. falciparum in other geographic regions of sub-Saharan Africa.
The aims of the present study were to investigate whether the TRAP gene is under diversifying selection in Bioko P. falciparum and to elucidate how TRAP gene is differentiated among P. falciparum populations. This research would be helpful not only for understanding the molecular evolution of the TRAP gene in P. falciparum but also for the improvement of peptide vaccines based on the TRAP antigen.
Discussion
As
PfTRAP was the potential candidate for anti-malarial vaccine and there are several
PfTRAP-based vaccines undergoing the clinical trials [
25‐
27], the worldwide information of its polymorphism was necessary and important for design and improvement of an effective vaccine. In this study,
PfTRAP gene data of Bioko Island, Equatorial Guinea was presented and submitted to public database, which had improved the global malarial database. Overall, with the polymorphism analysis, Bioko
PfTRAP exhibited the high polymorphism, which is consistent with
PfTRAP from other African countries but significantly distinct with the relatively low polymorphic Asian
PfTRAP. These phenomena consistence with the previous report about
P. falciparum circumsporozoite protein (
PfCSP) gene [
28], which also indicated that the similar polymorphic pattern between Bioko and Africa mainland countries. Moreover, the exploration and analysis of other vaccine candidate genes were also analysed previously, including pre-erythrocytic stage CSP gene, erythrocytic phase merozoite surface protein (MSP-1/2) and asexual blood stage apical membrane antigen-1 (AMA-1) gene [
28‐
30]. These results shown that the polymorphism of candidate genes associated with malaria vaccines in Africa has been at a high level for a long time.
As for the natural selection analysis of Bioko Island PfTRAP, the results obtained by the two different analytical methods are not consistent. The result of dN–dS is 6.2231 (p < 0.05), which is significantly hinted at a natural selection, while the value of Tajima’s D is − 0.41438 (p > 0.05), which is not significant based on Tajima’s D significance levels. For these two results are different, it cannot be concluded with certainty that the PfTRAP on Bioko island has been affected by natural selection, but continued monitoring is still recommended.
In the sight of the haplotype distribution and relation network, haplotypes of Bioko and other African countries distributed scattered while Asian ones are tended to cluster. This phenomenon is in line with the polymorphism result, which shows more mutations appear in African area and thereby lead to the abundant haplotypes. Moreover, the vast majority of these haplotypes are presented as singletons and the high prevalence of singleton is probably associated with the intensity of transmission or rapid expansion of population. Even so, the genetic differentiation between African countries shows limited and so do Asian countries, but an obvious genetic differentiation is found between countries which come from different continents. It might be explained with the population segregation of
Anopheles, the host of
P. falciparum, caused by the geographical separation. But interestingly, though Bioko Island is an island separated from African mainland by the Atlantic Ocean, its
PfTRAP gene shows low genetic differentiation with other African mainland countries. This result might be explained by the work of Guerra et al. [
31,
32], which reported that the strong connection of human movement between Bioko and the mainland Equatorial Guinea (EG), determine a high vulnerability of Bioko to malaria importation; these studies reported that the odds of malaria infection in travellers who had been to mainland EG were more than three times the rest of the population, which confirmed that the majority malaria cases are actively imported by off-island travelers to mainland EG [
31,
32]. In general, the non-negligible geographical characteristic might provide a new insight for the development of universal
PfTRAP-based vaccine.
Antigen polymorphism has been a major obstacle in the way of developing effective vaccines. Recent studies have highlighted the importance of protective roles of CD8+ T-cell and memory T-cell responses to
PfTRAP from clinical malaria cases [
33,
34]. Mutations on the surface of the antigen make it more difficult for the host immune system to recognize the antigen, and even lead to immune avoidance and reduce the immune effect. The present study had found a large number of substitutions located at the antigen epitopes, and the destructive prediction was presented. The destructive prediction result in this study reflect the potential destructive effect on the protein structure and further impaction of TRAP function. As it is known that TRAP is a protein that plays an important role in the sporozoite gliding motility, hepatocyte invasion and establishment of infection in the vertebrate host [
6‐
8], thus ‘damaging mutations’ might affect these functions but it would not be a threat to survival, which could explain that why the parasites with 'damaging mutations' still alive and be detected. Furthermore, TRAP as a vaccine candidate gene of great potential, the ‘damaging mutations’ probably affect the effectiveness of the vaccine, for the protein surface structure were changed. Several mutations were predicted as damaging (I116T, L122I, Y128F, G228V and P299S), and Y128F is noteworthy with global frequency of 21%. Some ‘possibly damaging’ mutations such as E46Q, I116S and T134S were also found in high frequency globally (24%, 13% and 37%, respectively). As these mutations were in such high frequency and were predicted as damaging to TRAP function or structure, the follow-up continuous monitoring project is worth to pay special attention to.
Nowadays, several malaria vaccines encoding the pre-erythrocytic antigen ME-TRAP, which often coupled with different adjuvants such as Chimpanzee adenovirus (ChAd63) or modified vaccinia Ankara (MVA), had been developed and issued by researchers have entered the clinical trial stage [
26,
27]. Still, these effects are not ideal for the goal of developing a globally effective vaccine. Some researchers had put forward a new insight that CSP-TRAP fusion antigens (TRAP N-terminal domains fused to circumsporozoite protein C-terminus with or without repeat region) could produce an effective host immune and it has been validated in vitro cell experiments [
35]. In this global analysis, the TRAP N-terminal domains (including Signal Sequences, A-domain and TSR) showed active genetic mutation, especially in A-domain, and there were 8 mutations predicted to do harm to protein structure or function. It presents the suggestion that the application of TRAP N-terminal domains in the vaccine components might deserve more observation and in-depth assessment. Moreover, as the previous research shown, there are numerous epitopes were predicted in the conserved regions that signifies the possibility of the development of a universal TRAP-based malaria vaccine design [
36]. As TRAP showed its great potential in inducing immunity, the systematic statistics and analysis of the polymorphism based on the genetic data from global malaria endemic regions shows a more important role in the development of TRAP-related vaccines.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.